Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashleigh S Davey

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Immunology and Cell Biology|June 28, 2021
Hello Possums!Melissa J Call, Ashleigh S Davey
Cancers|December 30, 2020
The Influence of Chimeric Antigen Receptor Structural Domains on Clinical Outcomes and Associated ToxicitiesAshleigh S Davey, Matthew E Call, Melissa J Call
Elife|May 4, 2022
De novo-designed transmembrane domains tune engineered receptor functionsAssaf Elazar, Nicholas J Chandler, Ashleigh S Davey, et al.
Clinical & Translational Immunology|July 25, 2020
Enhancing chimeric antigen receptor T-cell immunotherapy against cancer using a nanoemulsion-based vaccine targeting cross-presenting dendritic cellsJack D Chan, Bianca von Scheidt, Bijun Zeng, et al.
Clinical & Translational Immunology|November 27, 2019
Tissue-specific tumor microenvironments influence responses to immunotherapiesAmanda J Oliver, Ashleigh S Davey, Simon P Keam, et al.
Clinical & Translational Immunology|August 22, 2020
Novel combination immunotherapy for pancreatic cancer: potent anti-tumor effects with CD40 agonist and interleukin-15 treatmentJonas Rm Van Audenaerde, Elly Marcq, Bianca von Scheidt, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Immunology and Cell Biology|June 28, 2021
Hello Possums!Melissa J Call, Ashleigh S Davey
Cancers|December 30, 2020
The Influence of Chimeric Antigen Receptor Structural Domains on Clinical Outcomes and Associated ToxicitiesAshleigh S Davey, Matthew E Call, Melissa J Call
Elife|May 4, 2022
De novo-designed transmembrane domains tune engineered receptor functionsAssaf Elazar, Nicholas J Chandler, Ashleigh S Davey, et al.
Clinical & Translational Immunology|July 25, 2020
Enhancing chimeric antigen receptor T-cell immunotherapy against cancer using a nanoemulsion-based vaccine targeting cross-presenting dendritic cellsJack D Chan, Bianca von Scheidt, Bijun Zeng, et al.
Clinical & Translational Immunology|November 27, 2019
Tissue-specific tumor microenvironments influence responses to immunotherapiesAmanda J Oliver, Ashleigh S Davey, Simon P Keam, et al.
Clinical & Translational Immunology|August 22, 2020
Novel combination immunotherapy for pancreatic cancer: potent anti-tumor effects with CD40 agonist and interleukin-15 treatmentJonas Rm Van Audenaerde, Elly Marcq, Bianca von Scheidt, et al.
Pageof 1